Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 08 2023 - 7:10AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2023
Commission File Number: 001-41641
SHL TELEMEDICINE
LTD.
(Translation of registrant’s
name into English)
90 Yigal Alon Street
Tel Aviv 67891, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
INFORMATION CONTAINED IN THIS FORM 6-K
REPORT
On
May 8, 2023, SHL Telemedicine Ltd. (the “Company”) announced that a Special General Meeting of Shareholders of the
Company (the “Special General Meeting”) will be held on Thursday, June 22, 2023, at 5:00 p.m., Israel time, at the
offices of the Company at Ashdar Building – 2nd Floor, 90 Yigal Alon Street, Tel Aviv, Israel, and published
its Proxy Statement in connection with the Special General Meeting. The Notice of Special General Meeting of Shareholders and the Proxy
Statement in connection with the Special General Meeting are attached hereto as Exhibit 99.1 and are incorporated herein
by reference.
A copy of the Voting Instruction
Form for holders of the Company’s American Depositary Shares (“ADSs”) being distributed by The Bank of New York
Mellon, the Depositary for the Company’s ADS program, is attached hereto as Exhibit 99.2 and is incorporated herein
by reference.
A form of Voting Ballot for
holders of the Company’s ordinary shares is attached hereto as Exhibit 99.3 and is incorporated herein by reference.
This
Report on Form 6-K, including the Notice for the Special General Meeting, the Proxy Statement, the Voting Instruction Form for
holders of the Company’s ADSs and the form of Voting Ballot for holders of the Company’s ordinary shares attached to this
Report on Form 6-K, will also be made available on the Company’s corporate website at www.shl-telemedicine.com.
Information contained on, or that can be accessed through, the Company’s website, does not constitute a part of this Report on Form 6-K,
nor does it form part of the proxy solicitation materials in connection with the Special General Meeting. The Company has included its
website address in this Report on Form 6-K solely as an inactive textual reference. The Company will post on its website any materials
in connection with the Special General Meeting required to be posted on such website under applicable corporate or securities laws and
regulations.
Exhibit Description
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| SHL Telemedicine Ltd. |
| | |
| By: | /s/ Amir Hai |
| | Amir Hai |
| | Chief Financial
Officer |
May 8, 2023
SHL Telemedicine (PK) (USOTC:SMDCF)
Historical Stock Chart
From Jun 2024 to Jul 2024
SHL Telemedicine (PK) (USOTC:SMDCF)
Historical Stock Chart
From Jul 2023 to Jul 2024